Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Clinical Trial ID NCT02466568

PubWeight™ 1.67‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02466568

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PD-1/PD-L1 blockade in cancer treatment: perspectives and issues. Int J Clin Oncol 2016 0.95
2 Revisiting of cancer vaccine?-Specific immunotherapy comes to field with the biomarker. Ann Transl Med 2016 0.75
Next 100